文献速递乳腺癌放疗

乳腺癌加速放疗5次与15次分次方案的健康相关生活质量比较

Health-related quality of life after accelerated breast irradiation in five fractions: A comparison with fifteen fractions.
PubMed 文献 · Radiother Oncol · 2020-07-11

本研究比较了530例接受15次分次放疗和196例接受5次分次(10-12天)加速放疗的乳腺癌患者健康相关生活质量(HRQoL)。采用EORTC QLQ-C30、BR23及Breast-Q问卷评估基线、放疗后2-4周及1年的评分。结果显示5次分次方案在放疗后2-4周身体幸福感恶化更少,1年后疼痛、手臂和乳房症状及未来展望的临床重要改善患者更多。

要点

  • 5次分次加速放疗在放疗后2-4周身体幸福感恶化少于15次分次方案
  • 放疗后1年,5次分次方案在疼痛、手臂和乳房症状及未来展望方面报告临床重要改善的患者更多
  • 5次分次方案(10-12天)较15次分次方案(3周)总体HRQoL改善更多、恶化更少

核心结论

  • 10-12天内完成5次分次放疗较3周内15次分次方案带来更多HRQoL改善和更少恶化。

研究设计与样本

  • 研究纳入530例接受15次分次放疗和196例接受5次分次放疗的乳腺癌患者,患者来自评估HRQoL的不同试验。
  • 采用EORTC QLQ-C30、BR23及Breast-Q问卷的放疗相关条目,比较基线评分与放疗后2-4周及1年评分。

主要发现

  • 5次分次组患者在放疗后2-4周身体幸福感恶化较少。
  • 放疗后1年,5次分次组更多患者报告疼痛、手臂和乳房症状及未来展望的临床重要改善。

关键数值与推荐

  • 5次分次方案为10-12天内完成5次放疗,15次分次方案为3周内完成15次放疗。
  • HRQoL评估时间点为基线、放疗后2-4周及放疗后1年。

临床怎么用

  • 对于乳腺癌术后放疗患者,可考虑采用5次分次加速方案以缩短治疗时间并改善HRQoL。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: In breast cancer patients, duration of illness and treatment have a negative impact on the quality of life. The duration of radiotherapy can be shortened by reducing the number of treatment fractions. In this study, the impact of an accelerated breast irradiation schedule in 5 fractions over 10 to 12 days on health-related quality of life (HRQoL) was investigated and compared to a standard hypofractionation schedule of 15 fractions. METHODOLOGY: The study population was composed of 530 patients treated in 15 fractions and 196 patients treated in 5 fractions. Patients were included in different trials evaluating HRQoL. Radiotherapy-related items of the EORTC QLQ-C30 and BR23 and Breast-Q questionnaires were evaluated by comparing baseline scores to scores at 2-4 weeks and 1 year after radiotherapy. Clinically important improvements and deteriorations of HRQoL were compared between the 2 radiation schedules. RESULTS: Patients treated in 5 fractions show less deterioration of physical well-being 2-4 weeks after radiotherapy. One year after radiotherapy, the 5 fractions schedule results in more patients reporting a clinically important improvement in pain, arm and breast symptoms and future perspective. CONCLUSION: Radiotherapy in 5 fractions over 10-12 days results in more improvement and less deterioration of HRQoL than a 15 fractions schedule over 3 weeks.

来源:Radiother Oncol,查看原文。版权归原作者所有。

引用

  1. Van Hulle H, Vakaet V, Bultijnck R, et al. Health-related quality of life after accelerated breast irradiation in five fractions: A comparison with fifteen fractions. Radiother Oncol. 2020. PMID: 32663539. doi:10.1016/j.radonc.2020.07.007

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。